AU:ALA Stock Latest News
Company AnnouncementsArovella Reports Director’s Indirect Securities Interest Change2d ago
Company AnnouncementsArovella Director Receives Eight Million Performance Rights1w ago
Company AnnouncementsArovella Issues 8 Million Unquoted Performance Rights1w ago
Company AnnouncementsArovella Updates Constitution After Shareholder Approval1w ago
Company AnnouncementsArovella Shareholders Approve Most Annual Meeting Resolutions1w ago
Company AnnouncementsArovella Confirms Nicole Van Der Weerden as CEO1w ago
- Company AnnouncementsArovella doses first patient in phase 1 trial of off-the-shelf cell therapy ALA-1012w ago
Company AnnouncementsArovella Advances Off-the-Shelf CAR-iNKT Trials as Cash Position Strengthens3w ago
Company AnnouncementsArovella boosts off-the-shelf CAR-iNKT trial readiness with second clinical batch release1M ago- Company AnnouncementsArovella Showcases iNKT Cell Therapy Platform at Major Cell and Gene Meeting1M ago
Company AnnouncementsArovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial1M agoCompany AnnouncementsArovella Deepens ESG Commitment Ahead of Australia’s Sustainability Rules1M ago
Company AnnouncementsArovella Sets Hybrid 2026 AGM and Shifts to Default Digital Communications2M ago
Company AnnouncementsArovella Details Governance Framework in 2026 Corporate Statement2M ago
Company AnnouncementsArovella lodges 2026 corporate governance statement and Appendix 4G2M ago- Company AnnouncementsArovella Narrows Annual Loss as Net Tangible Assets Per Share Fall2M ago
- Company AnnouncementsArovella Issues 9.7 Million Unquoted Options Under Employee Incentive Scheme3M ago
Company AnnouncementsArovella outlines strategy and ALA-101 trial timeline in investor webinar3M ago
